SLCO1B3 and cancer: Notably, systemic ganciclovir treatment in mice harboring cancer cells expressing the RNA trans-splicing molecule RTM44 led to a marked reduction in both tumor volume and weight, underscoring the potential applicability of RTM44-mediated cancer gene CT-SLCO1B3 across a range of malignancies [114].